信达生物(01801.HK)获摩根大通增持40.86万股

Group 1 - JPMorgan Chase & Co. increased its stake in Innovent Biologics (01801.HK) by purchasing 408,600 shares at an average price of HKD 84.9352 per share, totaling approximately HKD 34.71 million [1] - Following this transaction, JPMorgan's total holdings in Innovent Biologics rose to 86,908,068 shares, with the ownership percentage increasing from 4.98% to 5.00% [1]